New Drug Regimen Could Improve XDR-TB Treatment

A clinical trial to test a new treatment for drug-resistant TB, or XDR-TB, is underway in South Africa. The non-profit TB Alliance and its partners launched the new study called “Nix-TB (New Investigational Drugs for XDR-TB).” The Alliance says the trial is a critical step in the development of a universal treatment for all types of tuberculosis.  It is the first study to test an all-oral drug regimen that has the potential to shorten, simplify and improve treatment for...

© La Voix de l'Amérique - jeudi 4 juin 2015